Please Wait.....
Report
Global Neuromodulation Devices Market Report and Forecast 2023-2031
Market Report I 2023-04-14 I 140 Pages I EMR Inc.
Global Neuromodulation Devices Market Report and Forecast 2023-2031
Global Neuromodulation Devices Market Outlook
The global neuromodulation devices market is expected to witness significant growth in the coming years, driven by factors such as the increasing prevalence of neurological disorders, the rise in the geriatric population, and advancements in neuromodulation technologies. The market is likely to grow at a rate of 10.5% in the forecast period of 2023-2031 to reach a market value of USD 19.54 billion by 2031.
Neuromodulation Devices Market: Introduction
The global neuromodulation devices market refers to the market for medical devices used to deliver electrical or chemical stimulation to the nervous system. Neuromodulation devices are primarily used for the treatment of neurological disorders such as chronic pain, Parkinson's disease, epilepsy, and depression. The market is being driven by factors such as the increasing prevalence of neurological disorders, the rise in the geriatric population, and advancements in neuromodulation technologies.
Neuromodulation Devices Market- Application and Usage
Neuromodulation devices are primarily used for the treatment of neurological disorders such as chronic pain, Parkinson's disease, epilepsy, and depression. These devices work by delivering electrical or chemical stimulation to specific areas of the nervous system to modulate its activity and restore normal functioning. Neuromodulation therapies involve the delivery of electrical or chemical stimulation to specific areas of the nervous system to modulate its activity and restore normal functioning. These therapies have been shown to be effective in reducing pain, improving motor symptoms, and enhancing mood in patients with neurological disorders.
One of the most common applications of neuromodulation devices is in the treatment of chronic pain. Spinal cord stimulators and peripheral nerve stimulators are often used to manage pain that is refractory to other treatments. These devices work by delivering electrical impulses to the nerves that transmit pain signals, thereby reducing the sensation of pain.
Neuromodulation devices are also used in the treatment of movement disorders such as Parkinson's disease and essential tremor. Deep brain stimulators are implanted in the brain and deliver electrical impulses to specific areas to help control tremors and other symptoms.
Epilepsy is another condition that can be treated using neuromodulation devices. Vagus nerve stimulators are often used in the treatment of epilepsy that is refractory to medications. These devices work by delivering electrical impulses to the vagus nerve, which can help reduce the frequency and severity of seizures. Neuromodulation devices are also used in the treatment of depression. Transcranial magnetic stimulators are non-invasive devices that deliver magnetic pulses to the brain to help regulate mood.
Overall, neuromodulation devices are an important tool in the treatment of a variety of neurological disorders. They offer a minimally invasive alternative to traditional treatments and can improve the quality of life for patients with these conditions.
Neuromodulation Devices Market Segmentations
The market can be categorised into type, application, indication, distribution channel, and region.
Market Breakup by Type
- Invasive
- Non-Invasive
- Others
Market Breakup by Application
- Internal Neuromodulation
? Spinal Cord Stimulation
? Deep Brain Stimulation
? Vagus Nerve Stimulation
? Sacral Nerve Stimulation
? Gastric Electric Stimulation
- External Neuromodulation
? Transcutaneous Electrical Nerve Stimulation
? Transcranial Magnetic Stimulation
? Respiratory Electrical Stimulation
- Others
Market Breakup by Indication
- Pain Management
- Neurological Disorders
- Respiratory Disorders
- Others
Market Breakup by Distribution Channels
- Hospitals
- Testing Laboratories
- Research Laboratories
Neuromodulation Devices Market Breakup by Region
- North America
? United States of America
? Canada
- Europe
? United Kingdom
? Germany
? France
? Italy
? Others
- Asia Pacific
? China
? Japan
? India
? ASEAN
? Australia
? Others
- Latin America
? Brazil
? Argentina
? Mexico
? Others
- Middle East and Africa
? Saudi Arabia
? United Arab Emirates
? Nigeria
? South Africa
? Others
Neuromodulation Devices Market Scenario
The neuromodulation Devices market is being driven by factors such as the increasing prevalence of neurological disorders, the rise in the geriatric population, and advancements in neuromodulation technologies. North America dominated the global neuromodulation devices market in 2020, followed by Europe and the Asia Pacific. The high prevalence of neurological disorders, favourable reimbursement policies, and the presence of many key players in the region are driving the growth of the market in North America and Europe.
The Asia Pacific region is expected to witness the highest CAGR during the forecast period, owing to the increasing prevalence of neurological disorders and the rising healthcare expenditure in the region. Moreover, the growing demand for minimally invasive procedures, advancements in healthcare infrastructure, and increasing investments in research and development activities are expected to fuel the growth of the neuromodulation devices market in the Asia Pacific region.
Key Players in the Global Neuromodulation Devices Market
The report gives an in-depth analysis of the key players involved in the neuromodulation devices market, sponsors manufacturing the drugs, and putting them through trials to get FDA approvals. The companies included in the market are as follows:
- NeuroPace, Inc.
- electroCore, Inc.
- Medtronic plc
- LivaNova, PLC
- Boston Scientific Corporation
- Neuronetics, Inc.
- NeuroSigma, Inc.
- Nevro Corp.
- Synapse Biomedical, Inc.
- Bioventus
1 Preface
1.1 Objectives of the Study
1.1.1 Research Objectives
1.1.2 Key Findings of the Report
1.2 Limitations of the Study and Scope for Future Research
2 Research Methodology
3 Executive Summary
4 Global Neuromodulation Devices Market
4.1 Global Neuromodulation Devices Market Overview
4.2 Global Neuromodulation Devices Market Analysis
4.2.1 Market Overview
4.2.1.1 Global Neuromodulation Devices Market Historical Value (2016-2022)
4.2.1.2 Global Neuromodulation Devices Market Forecast Value (2023-2031)
4.3 Global Neuromodulation Devices Market by Type
4.3.1 Market Overview
4.3.1.1 Invasive
4.3.1.2 Non-Invasive
4.3.1.3 Others
4.4 Global Neuromodulation Devices Market by Application
4.4.1 Market Overview
4.4.1.1 Internal Neuromodulation
4.4.1.1.1 Spinal Cord Stimulation
4.4.1.1.2 Deep Brain Stimulation
4.4.1.1.3 Vagus Nerve Stimulation
4.4.1.1.4 Sacral Nerve Stimulation
4.4.1.1.5 Gastric Electric Stimulation
4.4.1.2 External Neuromodulation
4.4.1.2.1 Transcutaneous Electrical Nerve Stimulation
4.4.1.2.2 Transcranial Magnetic Stimulation
4.4.1.2.3 Respiratory Electrical Stimulation
4.4.1.3 Others
4.5 Global Neuromodulation Devices Market by Indication
4.5.1 Market Overview
4.5.1.1 Pain Management
4.5.1.2 Neurological Disorders
4.5.1.3 Respiratory Disorders
4.5.1.4 Others
4.6 Global Neuromodulation Devices Market by Distribution Channels
4.6.1 Market Overview
4.6.1.1 Hospitals
4.6.1.2 Testing Laboratories
4.6.1.3 Research Laboratories
4.7 Global Neuromodulation Devices Market by Region
4.7.1 Market Overview
4.7.1.1 North America
4.7.1.2 Europe
4.7.1.3 Asia Pacific
4.7.1.4 Latin America
4.7.1.5 Middle East and Africa
4.7.2 North America
4.7.2.1 Historical Trend (2016-2022)
4.7.2.2 Forecast Trend (2023-2031)
4.7.2.3 Break Up by Country
4.7.2.3.1 United States of America
4.7.2.3.2 Canada
4.7.3 Europe
4.7.3.1 Historical Trend (2016-2022)
4.7.3.2 Forecast Trend (2023-2031)
4.7.3.3 Break Up by Country
4.7.3.3.1 United Kingdom
4.7.3.3.2 Germany
4.7.3.3.3 France
4.7.3.3.4 Italy
4.7.3.3.5 Others
4.7.4 Asia Pacific
4.7.4.1 Historical Trend (2016-2022)
4.7.4.2 Forecast Trend (2023-2031)
4.7.4.3 Break Up by Country
4.7.4.3.1 China
4.7.4.3.2 Japan
4.7.4.3.3 India
4.7.4.3.4 ASEAN
4.7.4.3.5 Australia
4.7.4.3.6 Others
4.7.5 Latin America
4.7.5.1 Historical Trend (2016-2022)
4.7.5.2 Forecast Trend (2023-2031)
4.7.5.3 Break Up by Country
4.7.5.3.1 Brazil
4.7.5.3.2 Argentina
4.7.5.3.3 Mexico
4.7.5.3.4 Others
4.7.6 Middle East and Africa
4.7.6.1 Historical Trend (2016-2022)
4.7.6.2 Forecast Trend (2023-2031)
4.7.6.3 Break Up by Country
4.7.6.3.1 Saudi Arabia
4.7.6.3.2 United Arab Emirates
4.7.6.3.3 Nigeria
4.7.6.3.4 South Africa
4.7.6.3.5 Others
5 Trade Data Analysis by HS Code
5.1 Neurostimulators- 90189099
5.2 Implantable Neurostimulators- 90189098
6 Current Scenario Evaluation and Regulatory Framework
6.1 Emerging Therapies and Clinical Trials Synopsis
6.2 Patent Landscape
6.2.1 Patent Overview
6.2.1.1 Patent Status and Expiry
6.2.1.2 Timelines from Device Development to Commercial Launch
6.2.1.3 New Device Application
6.2.1.3.1 Documentation and Approval Process
6.3 Cost of Treatment
6.4 Regulatory Framework
6.4.1 Regulatory Overview
6.4.1.1 US FDA
6.4.1.2 EU EMA
6.4.1.3 INDIA CDSCO
6.4.1.4 JAPAN PMDA
6.4.1.5 Others
7 Global Neuromodulation Devices Market Dynamics
7.1 Market Drivers and Constraints
7.2 SWOT Analysis
7.3 Porter's Five Forces Model
7.4 Key Demand Indicators
7.5 Key Price Indicators
7.6 Industry Events, Initiatives, and Trends
7.7 Value Chain Analysis
8 Supplier Landscape
8.1 NeuroPace, Inc.
8.1.1 Company Overview
8.1.2 Product Portfolio
8.1.3 Demographic Reach and Achievements
8.1.4 Mergers and Acquisitions
8.1.5 Certifications
8.2 electroCore, Inc.
8.2.1 Company Overview
8.2.2 Product Portfolio
8.2.3 Demographic Reach and Achievements
8.2.4 Mergers and Acquisitions
8.2.5 Certifications
8.3 Medtronic plc
8.3.1 Company Overview
8.3.2 Product Portfolio
8.3.3 Demographic Reach and Achievements
8.3.4 Mergers and Acquisitions
8.3.5 Certifications
8.4 LivaNova, PLC
8.4.1 Company Overview
8.4.2 Product Portfolio
8.4.3 Demographic Reach and Achievements
8.4.4 Mergers and Acquisitions
8.4.5 Certifications
8.5 Boston Scientific Corporation
8.5.1 Company Overview
8.5.2 Product Portfolio
8.5.3 Demographic Reach and Achievements
8.5.4 Mergers and Acquisitions
8.5.5 Certifications
8.6 Neuronetics, Inc.
8.6.1 Company Overview
8.6.2 Product Portfolio
8.6.3 Demographic Reach and Achievements
8.6.4 Mergers and Acquisitions
8.6.5 Certifications
8.7 NeuroSigma, Inc.
8.7.1 Company Overview
8.7.2 Product Portfolio
8.7.3 Demographic Reach and Achievements
8.7.4 Mergers and Acquisitions
8.7.5 Certifications
8.8 Nevro Corp.
8.8.1 Company Overview
8.8.2 Product Portfolio
8.8.3 Demographic Reach and Achievements
8.8.4 Mergers and Acquisitions
8.8.5 Certifications
8.9 Synapse Biomedical, Inc.
8.9.1 Company Overview
8.9.2 Product Portfolio
8.9.3 Demographic Reach and Achievements
8.9.4 Mergers and Acquisitions
8.9.5 Certifications
8.10 Bioventus
8.10.1 Company Overview
8.10.2 Product Portfolio
8.10.3 Demographic Reach and Achievements
8.10.4 Mergers and Acquisitions
8.10.5 Certifications
9 Recommendations and Discussion
10 Pricing Models and Strategies (Additional Insight)
10.1 Overview
10.2 Cost Model
10.2.1 Manufacturing Cost Analysis
10.2.2 Procurement Cost Analysis
10.2.3 Clinical Trial Cost Factors
10.3 Pricing Strategies
10.3.1 Competitor Pricing Analysis
10.3.2 Key Assessment of Product Attributes
10.3.3 Pricing Benchmark
11 Global Neuromodulation Devices Distribution Model (Additional Insight)
11.1 Overview
11.2 Potential Distributors
11.3 Key Parameters for Distribution Partner Assessment
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security